Found: 4
Select item for more details and to access through your institution.
Cost-Effectiveness of Biosimilars vs Leflunomide in Patients With Rheumatoid Arthritis.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 6, p. e2418800, doi. 10.1001/jamanetworkopen.2024.18800
- By:
- Publication type:
- Article
Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis.
- Published in:
- BioDrugs, 2023, v. 37, n. 3, p. 409, doi. 10.1007/s40259-023-00589-3
- By:
- Publication type:
- Article
Risk and Factors associated with disease manifestations in systemic lupus erythematosus - lupus nephritis (RIFLE-LN): a ten-year risk prediction strategy derived from a cohort of 1652 patients.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1200732
- By:
- Publication type:
- Article
Adult-onset Still's disease after mRNA COVID-19 vaccination presenting with severe myocarditis with acute heart failure and cardiogenic shock: a case report.
- Published in:
- Hong Kong Medical Journal, 2023, v. 29, n. 2, p. 162, doi. 10.12809/hkmj2210110
- By:
- Publication type:
- Article